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Immunologic memory induced by pathogenic agents or vaccinations is inextricably linked
to long-lasting protection. Adequately maintained memory T and B cell pools assure a
fast, effective, and specific response against re-infections. Studies of immune responses
amongst residents of malaria endemic areas suggest that memory responses to Plasmodia
antigens appear to be neither adequately developed nor maintained, because persons
who survive episodes of childhood malaria remain vulnerable to persistent or intermittent
malaria infections. By contrast, multiple exposures of humans and laboratory rodents to
radiation-attenuated Plasmodia sporozoites (γ-spz) induces sterile and long-lasting protec-
tion against experimental sporozoite challenge. Protection is associated with MHC-class
I-dependent CD8T cells, the key effectors against pre-erythrocytic stage infection.We have
adopted the P. berghei γ-spz mouse model to study memory CD8 T cells that are specific
for antigens expressed by Pb liver-stage (LS) parasites and are found predominantly in the
liver. On the basis of phenotypic and functional characteristics, we have demonstrated that
liver CD8 T cells form two subsets: CD44hiCD62LloKLRG-1+CD107+CD127−CD122loCD8
T effector/effector memory (TE/EM) cells that are the dominant IFN-γ producers and
CD44hiCD62LhiKLRG-1−CD107−CD127+CD122hiCD8T central memory (TCM) cells. In this
review, we discuss our observations concerning the role of CD8 TE/EM and CD8 TCM cells
in the maintenance of protracted protective immunity against experimental malaria infec-
tion. Finally, we present a hypothesis consistent with a model whereby intrahepatic CD8
TCM cells, that are maintained in part by LS-Ag depot and by IL-15-mediated survival and
homeostatic proliferation, form a reservoir of cells ready for conscription to CD8TE/EM cells
needed to prevent re-infections.
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INTRODUCTION
One of the cardinal features of Ag-specific immune responses
elicited by infections or vaccinations is the persistence of optimally
effective memory T cells that are inextricably linked to long-
lasting protection (Ahmed and Gray, 1996). Adequately main-
tained memory T cells assure a fast, effective, and specific response
against reoccurring infections. Studies of protective immunity
amongst residents of malaria endemic areas indicate that pro-
tective immunity to Plasmodia antigens develops gradually after
multiple exposures over many years and, although associated with
a decline in clinical manifestations of the disease, it decays rapidly
once exposure to the parasite ceases (Langhorne et al., 2008).
However, it is not clear why protection does not persist after
malaria infection. We hypothesized (Krzych et al., 2000) that the
absence of adequately developed immunologic memory, which
stems from the tolerant milieu of the liver (Crispe, 2011), seques-
tration of the liver-stage antigens (LS-Ags) within hepatocytes,
and relatively short duration of the liver-phase infection, is mainly
responsible for the lack of lasting protection. Others suggested that
a phenomenon known as altered peptide ligand, resulting from
polymorphisms at CD8 T cell sites, induces antagonistic effects
that interfere with the priming and the survival of memory T
cells (Plebanski et al., 1999). Poor immunogenicity may also stem
from inadequate immunizing doses or immunologic interferences
from blood-stage parasites (Good et al., 2005; Urban et al., 2005).
Interestingly, currently conducted studies with the RTS,S vaccine,
which is based on Plasmodium falciparum circumsporozoite pro-
tein (CSP), indicate that protection is conferred to infants and
small children but it lasts for a relatively short period of time
(Abdulla et al., 2008).
In contrast, exposure of laboratory rodents (Nussenzweig et al.,
1967), monkeys (Nussenzweig et al., 1970), and humans (Clyde
et al., 1973) to radiation-attenuated (γ) Plasmodia sporozoites
(γ-spz) induces sterile and long-lasting protection. Plasmodia
γ-spz-induced protection is multifactorial (Nardin and Nussen-
zweig, 1993), involving antibody (Egan et al., 1993), CD4 (Nardin
et al., 1989), and CD8 T cell (Wizel et al., 1995) responses directed
primarily to CSP. However, blood-stage antigens also recall IL-4
producing memory CD4 T cells in protected subjects (Palmer and
Krzych, 2002) and LS antigen-1- (LSA-1) specific proliferative T
cell responses correlate with protection (Krzych et al., 1995).
CD8 T cells have been considered key effectors against pre-
erythrocytic stage infection. Evidence supporting the effector
function of CD8 T cells is based on studies in human (Malik
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et al., 1991) and animal (Schofield et al., 1987; Weiss et al., 1988;
Berenzon et al., 2003) models of γ-spz-induced protection, protec-
tion induced by genetically attenuated parasites (GAP) (Jobe et al.,
2007; Mueller et al., 2007; Tarun et al., 2007; Trimnell et al., 2009)
as well as on more recent observations made in models of pro-
tection induced by wild type Plasmodia sporozoites administered
under drug coverage (Nganou-Makamdop et al., 2012). Studies
conducted in malaria endemic areas confirm the involvement of
effector CD8 T cells in protection (Bejon et al., 2007). The effector
function is associated mainly with the production of inflammatory
cytokines such as IFN-γ or TNF-α that mediate elimination of the
parasite within the hepatocytes by the nitric oxide (NO) pathway
(Seguin et al., 1994). CD8 T cells also exhibit cytolytic activity
against targets that express antigens belonging to pre-erythrocytic
stage parasites (Hill et al., 1991; Malik et al., 1991; Trimnell et al.,
2009).
Our lab has adopted the P. berghei γ-spz (Pb γ-spz) mouse
model to study memory CD8 T cells against experimental malaria
infection. CD8 T cells that arise in Pb γ-spz-immunized B6
mice are specific for antigens expressed by the developmentally
aborted LS parasites (Berenzon et al., 2003) and antigen experi-
enced CD44hiCD8 T cells are found predominantly in the liver
(Guebre-Xabier et al., 1999). In this review, we mainly focus on
memory CD8 T cells in the maintenance of protracted protec-
tion in the Pb γ-spz model. We also comment on studies in other
model systems of sterile protection that extend our hypothesis by
demonstrating the necessity for late LS-Ags and the induction of
effector and memory CD8 T cells for lasting protection (Butler
et al., 2011; Teirlinck et al., 2011). We hypothesize that long-term
protection to pre-erythrocytic stage infection can be induced and
maintained. As such, it requires the formation and persistence of a
central memory (TCM) CD8 T cell reservoir, which is maintained
in part by LS-Ag depot and by IL-15 and which gives rise to IFN-γ
producing effector/effector memory (TE/EM) CD8 T cells during
re-infections.
PLASMODIA PARASITES IN THE MAMMALIAN HOST; THE
IMPORTANCE OF THE LIVER-STAGE
Plasmodia sporozoites are inoculated into a mammalian host from
the salivary glands of an Anopheles mosquito during its blood
meal. Sporozoites then quickly travel to the liver via the circula-
tory and/or lymphatic systems. In the liver, sporozoites undergo
further development before they emerge as blood-stage mero-
zoites that infect the red blood cells. Hence, in the mammalian
host the Plasmodium parasite exhibits three morphologically dis-
tinct phases of development: sporozoite-, liver-, and blood-stage.
During each stage, the parasite expresses, to some extent, unique
protein profiles. The sporozoite-associated proteins facilite par-
asite invasion of hepatocytes (Rogers et al., 1992; Frevert, 1994;
Robson et al., 1995; Fidock et al., 1997) and, under certain condi-
tions, are potent antigens for the induction of cellular and antibody
responses. For example, CSP-specific responses correlate with pro-
tection in humans (Hoffman et al., 2002) and mice (Schofield
et al., 1987). LS-Ags are expressed by the developing parasite
within the parasitophorous vacuole in hepatocytes (Mueller et al.,
2005; Prudencio et al., 2006) and they are considered to be the
major inducers of protective cellular immune responses against
the pre-erythrocytic stage parasite (Fidock et al., 1994; Bucci et al.,
2000). Proteins that characterize the erythrocytic stage are thought
to play a role in the invasion of red blood cells (Holder, 1996).
The mammalian liver plays a key role in the life cycle of the Plas-
modium parasite as the LS is not only pivotal for survival of the
parasite, but it also represents a significant period for the induc-
tion, effector phase, and the maintenance of immune memory
responses. Understanding immune events that occur in the liver
in model systems of protective immunity, as well as during natural
infection, will expand our knowledge of organ-specific immune
responses to Plasmodia antigens and hence facilitate exploitation
of these responses to expedite progress in vaccine development
against this serious disease.
A MODEL OF PROTRACTED PROTECTION INDUCED BY
PLASMODIA γ-SPZ
Plasmodia γ-spz-induced sterile and protracted protection is con-
sidered the gold standard of anti-malaria vaccines. Like infectious
sporozoites, γ-spz carrying CSP and other sporozoite-associated
proteins, invade the liver where they undergo aborted development
and express LS-Ags (Zechini et al., 1999; Hollingdale and Krzych,
2002). It is believed that antigens expressed by the underdeveloped
liver schizonts remain in the liver forming a LS-Ag depot (Scheller
and Azad, 1995), which is critical for induction and persistence of
Ag-specific protracted protective immunity (Krzych et al., 2000).
Treatment of animals with primaquine, a drug which disrupts LS
development, concurrently with the γ-spz-immunizations abol-
ishes lasting protection (Scheller and Azad, 1995; Berenzon et al.,
2003).
The prevailing state of tolerance in the liver allows for infec-
tious sporozoites to expand and continue their life cycle. However,
immunization with γ-spz reverses this tolerance to inflammation,
which is needed for the induction as well as persistence of adaptive
immune responses (Krzych, 1999). Before the invasion of hepato-
cytes, Pb γ-spz, like infectious sporozoites, pass through Kupffer
cells (KC) (Pradel and Frevert, 2001) changing them to become
high IL-12 producers (Steers et al., 2005). In contrast, infectious
sporozoites do not activate naïve KC to produce IL-12, and instead
downregulate IL-10 (Steers et al., 2005). The importance of IL-
12 was demonstrated as an inducer of IFN-γ and iNOS (Sedegah
et al., 1994; Seguin et al., 1994) and as a critical cytokine for the
development of CD8 T cell responses to pre-erythrocytic stage
malaria (Doolan and Hoffman, 1999).
The molecular form of the sporozoites might influence the
mode of sporozoite entry into KC, which, in turn, might dictate
intracellular localization of sporozoites, as has been recently shown
for DC interacting with other parasites (Cervi et al., 2004). On the
basis of in vitro conducted studies (Pradel and Frevert, 2001; Sil-
vie et al., 2004), the entry of infectious sporozoites is mediated by
membrane:membrane fusion and parasites localize in a vacuole
that does not co-localize with lysosomes so that sporozoites avoid
metabolic degradation before reaching hepatocytes. Conceivably,
γ-spz could be internalized by phagocytosis and channeled to
phagosomes for metabolic degradation and export by MHC-class
II and I molecules. A significant upregulation of MHC-class I
is evident on KC after sporozoite challenge of γ-spz-immune
mice. In sharp contrast, MHC-class I molecules are downregulated
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on KC during infection of naïve mice and their APC function
is severely reduced (Steers et al., 2005). Inflammatory cytokines
increase the expression of MHC-class I-peptide complexes on
APC by inducing immune proteosomes for more efficient gen-
eration of antigenic peptides for entry into the ER and loading
onto empty MHC-class I molecules (Khan et al., 2001). Accord-
ingly, KC from γ-spz-immune/challenged mice present peptides
and protein antigens to specific T cells. We propose that a cascade
of pro-inflammatory cytokines released during the innate immune
response induced by γ-spz leads to temporary local inflamma-
tion, which is perceived as a “danger signal” needed to trigger
proper responses from the adaptive immune system and lead to
long-lasting immune memory (Matzinger, 1994).
CD8 T CELLS MEDIATE PROTECTIVE IMMUNITY
Work based on in vivo depletion of CD8 T cells (Weiss et al., 1988)
unequivocally established CD8 T cells as key effectors in a rodent
model of protection against malaria. We confirmed these results
by demonstrating a failure to protect β2 microglobulin knockout
(β2m KO) mice (White et al., 1996) and KbDb KO mice (Krzych
and Schwenk, 2005) immunized with Pbγ-spz. Protection induced
by GAP spz is also CD8 T cell dependent as shown by us in β2m KO
mice immunized with Pb GAP spz (Jobe et al., 2007) and by others
in Py GAP protected mice after depletion of CD8 T cells (Trimnell
et al., 2009). We also established that effector CD8 T cells are MHC-
class I-restricted/dependent because protection is not transferred
by γ-spz-immune wt cells into β2m KO recipients as CD8 T cells
must recognize LS-Ag peptides presented by MHC-class I on APC
in the liver. The necessity for cognate peptide recognition by CD8
TE cells was confirmed in experiments using MHC-class I mis-
matched effector and target hepatocytes (Chakravarty et al., 2007).
The need for proximity between effector lymphocytes and target
hepatocytes was demonstrated (Rodrigues et al., 1992), as has the
ability of hepatocytes to present CSP to CD8 T cells (Bongfen et al.,
2007). Target LS-Ags that induce CD8 T cells are being currently
defined by us, as well as others (Doolan et al., 2003), using the
combination of genomic and proteomic approaches. For exam-
ple, targeted gene deletion reveals that Plasmodium sporozoite
low-complexity asparagine-rich protein is essential for early LS
development (Aly et al., 2011), whereas FabB/F gene (Vaughan
et al., 2009) is essential for late-LS development. Immunization of
mice with GAP spz with deletions of each of these genes induces
protective immunity. Interestingly, immunization with the late-
arresting fabb/f− parasites induces durable protection in several
mouse strains and across Plasmodia species, presumably because
these parasites express a broader repertoire of potential antigens
that activate a wider spectra of effector T cells (Butler et al., 2011).
The initial site of induction of liver-resident CD8 T cells
remains unclear. It is possible that these cells arise in the liver
after interaction with liver APC such as KC or DC that present
LS-Ags from developmentally aborted parasites. In support of this
hypothesis, we have observed that the number of cCD8α+ DC
increases in the liver concurrently with the number of Pb γ-spz
immunizations, while those in the spleen do not change. Addition-
ally, liver cDCs are very efficient at inducing CD8 TE/EM phenotype
and expression of IFN-γ, a process that is both MHC-class I-
and IL-12-dependent (Jobe et al., 2009). The possibility of local
activation of CD8 T cells by LS-Ags is quite attractive for several
reasons, but especially because it enables a rapid response during
re-infection. Although it has been shown that activated CD8 T
cells home to the liver to be eliminated as a way of purging their
destructive effector mechanism (Mehal et al., 1999), there is also
evidence that direct activation of naïve CD8 T cells occurs in the
liver (Bertolino et al., 2001; Klein and Crispe, 2006). Alternatively,
CD8 T cells might be induced in a draining LN by LS-Ag-loaded
DCs and during sporozoite challenge migrate to the liver, where
they might undergo further expansion. Although quite attractive,
migratory DC do not normally express the CD8α+ phenotype
(Belz et al., 2004) and the cCD8α+ DC are the major activators of
CD8 T cells in our system (Jobe et al., 2009). Although lack of firm
evidence supporting either scenario favors the prevailing view that
T cell activation occurs as a result of interaction with DC in the
LN, the possibility of an organ-specific activation of CD8 T cells
remains very attractive and should be explored further.
The development of TCR transgenic CD8 T cells specific for the
P. yoelii CSP immunodominant peptide SYVPSAEQI (CS-Tg) has
enabled the tracking of early immune responses (Sano et al., 2001).
After exposure to bites from Py γ-spz infected mosquitoes, IFN-γ
producing CS-Tg T cells were detected in the skin draining LN as
early as 48 h after immunization, while spleen and liver responses
were not detected until 72 h (Chakravarty et al., 2007). Accord-
ing to these results, CD8 TE cells are generated in the draining LN
near the infection (site of mosquito bite) (Chakravarty et al., 2007),
and then migrate to liver to kill infected hepatocytes, a process that
has been shown to be TAP-dependent, but endosome independent
(Cockburn et al., 2011). It is possible that the induction of CD8 TE
cells depends on their fine specificity and the site of parasite inoc-
ulation. Consequently, CSP-specific CD8 T cells would be induced
in the skin draining LN, as sporozoites that are trapped in the skin
shed CSP, which could be presented by DCs to T cells. In contrast,
LS-Ags, being expressed exclusively in the liver, might activate T
cells in the liver, or be transferred either directly or through liver-
resident APCs to the liver-draining LNs, to activate T cells there.
Owing to the paucity of antigen-specific cells naturally present at
the time of immunization or infection, it may not be possible to
precisely determine the location of initial priming events.
EFFECTOR LIVER CD8 T CELLS
Pb γ-spz-immune intrahepatic mononuclear cells (IHMC) con-
tain CD4 and CD8 T cells with inducible CD44hi CD25hi and
CD45RBlo phenotypic markers (Guebre-Xabier et al., 1999).
Expression of CD45RB, an activation/memory marker, changes
from CD45RBhi to CD45RBlo with increased antigen exposure
and the state of cellular maturation (Lee et al., 1990; Seder and
Ahmed, 2003). Although CD8 CD45RBlo T cells are present
in naïve liver, multiple immunizations with γ-spz stabilize and
increase the CD45RBlo (or CD62Llo) phenotype as well as other
phenotypic and functional attributes. For example, enhanced fre-
quencies of CD8 CD45RBlo T cells that secrete IFN-γ and express
KLRG-1hiCD107+ phenotype coincide with the induction of ster-
ile protection (Krzych et al., 2010). These observations are in
agreement with the transient expansion of T cells (Ahmed and
Gray, 1996; Badovinac et al., 2002) and the role of CD8 T cells as
effectors.
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Liver CD8 T cells from Pb γ-spz-immunized mice produce
enhanced IFN-γ 6 h after challenge and the response peaks around
day 7 after challenge (Berenzon et al., 2003). CD8 T cells that
produce IFN-γ followed by the induction of nitric oxide syn-
thetase (NOS) (Klotz et al., 1995; Doolan and Hoffman, 1999)
might be physiologically relevant to the process of elimination
of LS parasites: IFN-γ inhibits the hepatic stages of rodent and
human malaria both in vitro and in vivo (Mellouk et al., 1987);
injection of IFN-γ protects mice against sporozoite challenge (Fer-
reira et al., 1986); and immunization with γ-spz fails to generate
protection in IFN-γR KO mice (Tsuji et al., 1995). Moreover, a
reduced IFN-γ response from liver CD8 CD44hi T cells correlates
with decreased protection in mice (Nganou-Makamdop et al.,
2012); and Py CS-Tg T cells eliminate the parasite by a mech-
anism that depends upon rapid IFN-γ production (Sano et al.,
2001).
Secretion of IFN-γ by liver CD8 T cells would preclude the
need for direct lysis of hepatocytes, as IFN-γ could suppress
parasite growth by the few CD8 T cells that encounter infected
hepatocytes. IFN-γ could also contribute to protection indirectly
by upregulating MHC-class I and class II molecules and B7-1
and B7-2 co-stimulatory molecules on KC, DC, and hepato-
cytes. This, in turn, would further promote activation of CD8
TE cells.
The release of IFN-γ, which coincides with the activation of
CD8 T cells, is preceded by elevated production of IL-4, which
declines when IFN-γ reaches its peak (Krzych et al., 2000). The
reciprocal regulation between these two cytokines reflects the pre-
cise orchestration of functional activities among T cell subsets
induced by γ-spz. It is likely that IL-4 in the liver is produced
by NK T cells, whereas IFN-γ is produced primarily by CD8
T cells (Berenzon et al., 2003). This view is in agreement with
the observation that CD8 TE cells decline after inflammation
has subsided (Badovinac et al., 2002), whereas memory CD8
T cells persist, if they are supported by lymphokine-secreting
cells.
In our view, sustained protection requires various CD8 T cell
specificities, particularly those belonging to proteins expressed
during pre-erythrocytic LS development. It could be envisaged
that CSP-specific CD8 T cells initiate the effector stage of pro-
tection because they are the first cells to produce IFN-γ upon
encountering infectious sporozoites. Protracted protection might
require the subsequent activation of a second wave of CD8 T cells
specific for epitopes other than CSP, as they would have to target
hepatocytes by recognizing LS-Ags. Such concerted and function-
ally integrated activity provided by CD8 TE cells with multiple
specificities might be necessary to provide sustained protection.
In their recent study, Butler et al. (2011) propose that GAP par-
asites arrested during late-LS development induce stronger CD8
T cell responses and durable protection presumably because these
parasites contain a richer repertoire of antigens able to induce
effector T cells. Similar observations regarding the availability of
a more abundant level of late-LS-Ags have been made in a model
system of protection induced by P. bergehi sporozoites delivered by
the intravenous route under a drug coverage (Nganou-Makamdop
et al., 2012).
MEMORY CD8 T CELLS
The formation of optimally effective memory T cells is an essen-
tial feature of an adaptive immune response elicited by infections
and it is inextricably linked to long-lasting protective immu-
nity (Ahmed and Gray, 1996). Intrahepatic memory CD8 T
cells generated by immunization with Pb γ-spz segregate into at
least two distinct but developmentally related subsets: the IFN-
γ-producing CD44hiCD45RBloCD122loCD62Llo phenotype, or
TE/EM cells, which can be further subdivided based on the expres-
sion of IL7Rα (CD127) and KLRG-1 into TE (CD127−KLRG-1+)
or TEM (CD127+KLRG-1−); and the indolent IFN-γ produc-
ing CD44hiCD45RBhiCD122hiCD62Llo/hi phenotype, hence CD8
TCM cells. The elevated expression of CD122 (IL-15Rα) on CD8
TCM cells suggests that, in contrast to CD8 TE/EM cells, they are
IL-15-dependent (Berenzon et al., 2003; Krzych et al., 2010).
Recently, various phenotypic and functional attributes have
been evaluated in an effort to understand the differentiation of
memory CD8 T cells (Joshi et al., 2011). In addition, asymmetric
division (Ciocca et al., 2012), duration and strength of the TCR
signal (D’souza and Hedrick, 2006), and inflammatory cytokines
(Obar and Lefrancois, 2010) have been examined as requirements
for memory T cell development and differentiation. Nonetheless,
many questions remain regarding the regulation of memory cell
formation and in the case of organ-specific infections, like malaria,
additional aspects of memory CD8 T cell development and differ-
entiation need to be considered. We propose that these functionally
and phenotypically unique subsets of liver memory CD8 T cells
form an interactive network involving different phases of dynamic
cell activation and differentiation (Berenzon et al., 2003). The co-
presence of distinct subsets within the intrahepatic memory CD8
T cell pool in mice protected against malaria is consistent with an
earlier view that virally induced memory CD8 T cells are orga-
nized into subsets on the basis of distinct functional activities and
the maturation/activation status (Sallusto et al., 1999; Kaech et al.,
2002; Wherry et al., 2003).
Similar to the rapid responses mediated by influenza- and
Sendai-specific CD8 TE/EM cells (Hogan et al., 2001), intrahepatic
CD8 TE/EM cells from Pb γ-spz-immunized mice produce a copi-
ous amount of IFN-γ within 1–6 h after infection. Although the
pool of CD8 TE cells eventually contracts and the IFN-γ response
diminishes, the IFN-γ-producing memory T cells persist in the
livers of mice that maintain protracted protection against a re-
challenge (Berenzon et al., 2003; Nganou-Makamdop et al., 2012).
A decay of protection is typically accompanied by the decline of
IFN-γ-producing KLRG-1hiCD107hi CD8 T cells (Krzych et al.,
2010).
CD8 TCM cells also produce IFN-γ but the responses are low
and relatively short-lived. Therefore, these cells do not appear to
be directly involved in the elimination of the parasite. Instead, by
acquiring the CD122hi phenotype, liver CD8 TCM cells engage in
homeostatic proliferation, which qualifies them to function as a
reservoir to maintain the size of memory CD8 T cell pools (Judge
et al., 2002; Berenzon et al., 2003; Krzych and Schwenk, 2005).
The maintenance of memory pools is one of the prerequisites of a
memory T cell response because attrition, particularly of CD8 TE
cells, is inevitable during any infection (Badovinac et al., 2002).
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MECHANISMS FOR MAINTENANCE OF PROTECTION
INDUCED BY γ-spz
Evidence from our laboratory indicates that the persistence of
memory CD8 T cells correlates with the maintenance of protec-
tive immunity. Interestingly, the persistence of memory phenotype
CD8 T cells is restricted to liver lymphocytes, because splenic T
cells from the same group of γ-spz-immunized mice display a phe-
notype similar to splenic T cells from naïve mice (Guebre-Xabier
et al., 1999).
The persistence of memory CD8 T cells in the liver can be
accounted for by several co-existing mechanisms. First, some of
the memory T cells detected after immunization may be long-
lived memory cells derived from CD8 TE cells that survived
the contraction phase after sporozoite challenge and have not
lost their replicative abilities (Bannard et al., 2009). Second, the
CD44hiCD45RBlo CD8 T cells in the livers of long-term immune
mice may be derived from cells that constantly ingress to the liver
in response to the liver repository of Plasmodia antigens. The per-
sisting memory may also be derived from naive CD8 T cells that
do not quite acquire effector function during priming and sub-
sequent boost immunizations with Pb γ-spz. It appears unlikely
that they traffic to the liver from the spleen, because CD44hi CD8
T cells are not present in the spleens during protracted immunity;
it is possible, however, that they traffic from the draining celiac
LNs. Irrespective of whether maintenance of protection relies on
long-lived intrahepatic memory T cells or T cells that constantly
ingress to the liver, both require a repository of Plasmodia antigens
(Berenzon et al., 2003).
THE LS-Ag DEPOT IS REQUIRED FOR THE MAINTENANCE OF
PROTRACTED PROTECTION
There is ample contradictory evidence with respect to antigen
requirement for the persistence of memory T cells (Gray and
Matzinger, 1991; Murali-Krishna et al., 1999; Jelley-Gibbs et al.,
2005; Zammit et al., 2006). On the basis of results from our lab-
oratory, the persistence of a threshold of accumulated LS-Ags is
critical for the maintenance of protective immunity. Administra-
tion of primaquine at the time of immunization with Pb γ-spz
does not affect protection at primary challenge, but results in a loss
of protracted protection, which correlates with a decrease of CD8
TE/EM cells in the liver. The disruption of the intrahepatic-stage
parasite development prevents the formation of a local antigen
depot, which impedes the conscription of TCM into TE/EM CD8
T cells upon re-challenge. In contrast, delayed administration of
primaquine has no effect on lasting protective immunity (Beren-
zon et al., 2003). These results are indeed expected, as the primary
action of primaquine is against LS development, without affect-
ing the sporozoite stage, represented by CSP-specific CD8 T cells
(Hafalla et al., 2002; Cockburn et al., 2010).
Although most of the results from viral systems argue against
the need for antigen to maintain long-lived memory CD8 T cells
(Lau et al., 1994; Murali-Krishna et al., 1999), there is evidence that
T cell memory persists if a protracted restimulation of effector T
cells is maintained, either by persisting or by cross-reacting envi-
ronmental antigens (Zinkernagel et al., 1996; Jelley-Gibbs et al.,
2005). We suggest that antigen requirements might be quite dif-
ferent in malaria because the parasite exhibits tropism to the
liver, which is characterized by immunologic tolerance. The liver
antigen repository may be sufficient to play a unique role in dis-
tinguishing the “locally” activated liver memory T cells from those
found in the spleen or LN.
The precise location of the LS-Ag depot has not been estab-
lished. In principle, hepatocytes can function as APC. Although
there is no evidence that hepatocytes present LS-Ags to activate or
to maintain memory T cells, because so few hepatocytes become
infected by the invading sporozoites and they also are inefficient
as APC (Steers et al., 2005), hepatocytes may provide LS-Ag for
cross-presentation by either KC or cDC. It could be envisaged that
liver APCs internalize infected hepatocytes and engage in cross-
presentation of LS-Ag that gained entry from phagosomes into the
MHC-class I pathway. Exogenous particulate Ags were shown to
enter the MHC-class I pathway via phagosome-ER fusion (Gagnon
et al., 2002) or, as in the case of Toxoplasma gondii, fusion of the
parasitophorous vacuole with the ER (Goldszmid et al., 2009).
The mechanism of LS-Ag processing and presentation has not
been fully investigated; however, we demonstrated that adoptively
transferred liver CD11c+ DCs isolated from Pb γ-spz-immunized
mice confer sterile protection to naive mice during a primary Pb
sporozoite challenge (Jobe et al., 2009). In a recent study, it was
shown that proliferation of Py CS-Tg CD8 T cells transferred into
Py γ-spz-immunized mice can be maintained in the liver for up to
60 days post immunization. Depletion of CD11c prior to immu-
nization abolishes this response, which indicates a role for DC as
a possible source of CSP depot (Cockburn et al., 2010).
MAINTENANCE OF CENTRAL MEMORY CD8 T CELLS BY IL-15
It has been established that IL-15 promotes the survival of long-
term memory CD8 T cells by maintaining their homeostatic pro-
liferation, whereas IL-2 stimulates both the initial expansion and
subsequent contraction of T lymphocytes (Ku et al., 2000; Li et al.,
2001; Waldmann et al., 2001; Sprent and Surh, 2002). Although
the CD8 TCM cell subset represents a much smaller fraction of
the liver CD8 T cells, twice as many CD8 TCM cells are CD122hi
than TE/EM cells, which are primarily CD122lo (Berenzon et al.,
2003). On the basis of results from in vitro studies, only CD8 TCM
cells proliferate in the presence of IL-15 and these cells are severely
reduced in IL-15KO mice (Krzych et al., 2009). The enhanced sen-
sitivity of the CD8 TCM cells to reduced levels of IL-15 suggests
that this subset preferentially expand upon exposure to elevated
levels of IL-15 in the liver. It also implies that an optimal protec-
tive response requires a developmental compartmentalization of
CD8 T cells, with each subset performing not only a unique role,
but also relying on distinct regulatory mechanisms (Krzych et al.,
2009).
We explored the issue of IL-15 as a signal required for the main-
tenance of memory CD8 T cells in IL-15 deficient mice (Krzych
et al., 2009). Like wt mice, IL-15 KO mice are protected against a
primary challenge administered shortly after the last boost immu-
nization with Pb γ-spz. Protection is short-lived, however, as at
re-challenge 2 months later, the IL-15 deficient mice become par-
asitemic. Analysis of the CD8 T cell subsets at primary challenge
show an accumulation of CD8 TEM cells and a very small pool of
CD8 TCM cells. It appears, therefore, that in the absence of IL-15,
CD8 TEM cells might have developed directly from naïve CD8 T
www.frontiersin.org December 2012 | Volume 3 | Article 370 | 5
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Krzych et al. Memory CD8 T cells in malaria
cells as has been shown in other systems (Decaluwe et al., 2010).
Without the provision of IL-15, the critical reservoir of memory
CD8 T cells is severely reduced and hence unable to sustain a suf-
ficient number of cells needed during re-challenge. We observed a
near absence of CD8 TCM cells in IL-15 KO mice prior to secondary
challenge. The majority of CD8 TCM cells undergo severe attrition
as evidenced by the level of apoptosis mainly within the CD8 TCM
cells. Consequently, only∼1% of the cells remain in IL-15 deficient
mice in relation to∼7% in wt mice. Upon 2˚ challenge, the major-
ity of CD127hiCD8 TCM cells transition to CD127lo phenotype in
wt mice, but in IL-15KO mice few cells become CD127lo. These
observations strongly support our hypothesis that CD8 TE/EM cells
are conscripted from the CD8 TCM cells in a continuous, albeit
slow, process that occurs in the liver as a result of an increased
antigen load after repeated immunizations with γ-spz. An asso-
ciation between sterile protection and increased antigenic load of
late-LS parasites has also been demonstrated in another model
system using Pb sporozoites (Nganou-Makamdop et al., 2012).
The conscription of TE cells from the TCM reservoir also occurs
during infection, when large numbers of CD8 TEM cells would
be most needed to combat the parasite. For example, it has been
shown that a large number of Pb CS252–260-specific CD8 T cells
is needed to to maintain sterile protection in Balb/c mice chal-
lenged with Pb sporozoites (Schmidt et al., 2011). Compared to
many bacterial or viral infections, sterile immunity against malaria
infection requires 100–1000 fold higher numbers of CD8 TE cells
(Schmidt et al., 2008). The requirement for these large numbers of
antigen-specific CD8 T cells may be, in part, due to the short time
frame of the LS when the parasite is most vulnerable to immune
intervention.
In either case, CD8 TCM cell pool is maintained in the liver by
IL-15. IL-15 is produced by a variety of cell types (although not
by T cells) in response to signaling via TLRs or exposure to type
I IFN (Mattei et al., 2001). Pb γ-spz cause upregulation of IL-15
mRNA in KC (Krzych et al., 2009) and liver cDC (Jobe et al., 2007).
Upon encounter with specific antigen from the liver repository or
upon re-infections, the CD8 TCM cells would be driven to differen-
tiate into the CD44hiCD45RBloCD122lo phenotype that is easily
triggered by infectious sporozoites to produce IFN-γ. Recently, it
was demonstrated that CD8 T cell survival during influenza infec-
tion is promoted in the lung by trans-presentation of IL-15 by
pulmonary CD8α+DCs (McGill et al., 2010). There is evidence
(Dubois et al., 2002) that APC retain IL-15 bound to the IL-15Rα
chain to transactivate CD8 T cells expressing the IL-15Rβγc com-
plex. On the basis of our previously published results that liver
cDC activate CD8 T cells in a MHC-class I-dependent manner to
express CD44hi, up-regulate IL-15 mRNA (Jobe et al., 2009) and
express detectable IL-15 protein (Krzych et al., 2010), together with
KC they can function as APCs of LS-Ags and as trans-presenters of
IL-15 that target only liver CD8 TCM cells. Our hypothesis is sup-
ported by observations from in vitro conducted studies that only
CD8 TCM cells require trans-presentation of IL-15 in the context
of a concurrent signaling via TCR for optimal recall response, as
responses by CD8 TEM cells are not augmented by IL-15 (Kokaji
et al., 2008).
SUMMARY
MHC-class I-restricted CD8 T cells have been established as key
effectors in protective immunity against pre-erythrocytic-stage
malaria infection. The effector function is associated mainly with
the production of inflammatory cytokines such as IFN-γ or TNF-
α that mediate elimination of the parasite within the hepatocytes
by the NO pathway. The success of protection induced by γ-
spz depends upon the long-lived intrahepatic memory CD8 T
cells that consist of developmentally related subsets as CD8 TCM
and CD8 TEM cells. While the CD8 TEM cells are maintained
by the antigen-driven conscription of the CD8 TCM cells, the
latter representing a very broad spectrum of antigen-specific T
cells, is maintained by IL-15 and possibly the LS-Ag depot. This
arrangement assures a steady availability of antigen-specific T cells
should they be required to combat re-infection. The dependence
on specific antigen essentially controls the balance between the two
phenotypes and the differential expression of IL-15R prevents the
CD8 TEM cells from becoming activated in the event of sporadic
co-infections. However, it is the activated status of the intrahepatic
memory CD8 T cells that really distinguishes them from the mem-
ory CD8 T cells in the spleen and LN as it represents the sentinel
of a local, organ-specific infection.
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